Ozelle Unveils Next-Generation AI-Driven Diagnostics at WHX Labs Dubai 2026
Ozelle, a global leader in intelligent diagnostics, is gearing up to showcase its next-generation solution at the upcoming WHX Labs in Dubai from February 10 to 13, 2026. Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," the company promises to redefine diagnostics by advancing from traditional, standalone analyzers to smarter, ready-to-use solutions. These innovations aim to close the gap between precision in laboratory settings and the realities of clinical environments.
One of the standout features of Ozelle’s offering is its AI-activated complete blood morphology system, which transforms hematological diagnostics through high-resolution imaging combined with real-time algorithmic analysis. Rather than relying on conventional numerical data, this system identifies multi-classified cells, such as segmented neutrophils (NST), granule-segmented neutrophils (NSG), atypical lymphocytes (ALY), and reticulocytes (RET). This enhanced capability allows for earlier detection of abnormalities and more informed clinical decisions from just a single drop of blood.
Ozelle’s integrated solution also combines hematology, biochemistry, and immunoassays into a single workflow with no maintenance required. Clinicians have the flexibility to create on-demand panels tailored to specific scenarios. These can include infection typing using a complete blood count (CBC) combined with C-reactive protein (CRP) and serum amyloid A (SAA), diabetes management with CBC and hemoglobin A1c (HbA1c), or cardiac screening with CBC and NT-proBNP (N-terminal pro b-type natriuretic peptide).
This versatility not only streamlines diagnostics but also equips primary care clinics and pharmacies to deliver comprehensive results with unparalleled efficiency. A highlight of the WHX Labs presentation will be Ozelle’s intelligent AI tool (Open Dx), a unified diagnostic assistant embedded directly within the analyzer. This integrated system streamlines the workflow by merging test ordering, result review, and AI-assisted consulting.
Clinicians will benefit from this seamless transition from testing to interpretation, enhancing their confidence in decision-making. The platform will also elevate traditional static reports into dynamic, interactive diagnostics. It automatically identifies abnormal results, flags potential risks, and provides structured interpretations, thus transforming how diagnostics are communicated. With conversational AI capabilities, clinicians can delve deeper into results through an interactive report consultation.
In veterinary applications, the AI Workbench will support AI-assisted diagnostic advice and medication references tailored specifically to animal care, showcasing Ozelle's commitment to diverse healthcare sectors.
With a global footprint of over 50,000 installations, generating more than 50 million cellular images daily, Ozelle’s AI capabilities rest on a robust database exceeding 100 billion real data points. This invaluable resource serves to continuously hone validated algorithms through a proprietary industry-quality control system.
Ozelle extends an invitation to all attendees at WHX Labs Dubai (Stand S1.D58) for live demonstrations and interactive sessions. Witness firsthand how AI × CBM is set to shape the future of diagnostic testing. For personalized demonstrations or to arrange a meeting, contacting Ozelle is highly encouraged. With innovative advancements in diagnostics, Ozelle emphasizes the importance of transforming healthcare for better outcomes, aligning with the future of medicine.
For more information, visit www.ozellemed.com or reach out via email to [email protected]
One of the standout features of Ozelle’s offering is its AI-activated complete blood morphology system, which transforms hematological diagnostics through high-resolution imaging combined with real-time algorithmic analysis. Rather than relying on conventional numerical data, this system identifies multi-classified cells, such as segmented neutrophils (NST), granule-segmented neutrophils (NSG), atypical lymphocytes (ALY), and reticulocytes (RET). This enhanced capability allows for earlier detection of abnormalities and more informed clinical decisions from just a single drop of blood.
Ozelle’s integrated solution also combines hematology, biochemistry, and immunoassays into a single workflow with no maintenance required. Clinicians have the flexibility to create on-demand panels tailored to specific scenarios. These can include infection typing using a complete blood count (CBC) combined with C-reactive protein (CRP) and serum amyloid A (SAA), diabetes management with CBC and hemoglobin A1c (HbA1c), or cardiac screening with CBC and NT-proBNP (N-terminal pro b-type natriuretic peptide).
This versatility not only streamlines diagnostics but also equips primary care clinics and pharmacies to deliver comprehensive results with unparalleled efficiency. A highlight of the WHX Labs presentation will be Ozelle’s intelligent AI tool (Open Dx), a unified diagnostic assistant embedded directly within the analyzer. This integrated system streamlines the workflow by merging test ordering, result review, and AI-assisted consulting.
Clinicians will benefit from this seamless transition from testing to interpretation, enhancing their confidence in decision-making. The platform will also elevate traditional static reports into dynamic, interactive diagnostics. It automatically identifies abnormal results, flags potential risks, and provides structured interpretations, thus transforming how diagnostics are communicated. With conversational AI capabilities, clinicians can delve deeper into results through an interactive report consultation.
In veterinary applications, the AI Workbench will support AI-assisted diagnostic advice and medication references tailored specifically to animal care, showcasing Ozelle's commitment to diverse healthcare sectors.
With a global footprint of over 50,000 installations, generating more than 50 million cellular images daily, Ozelle’s AI capabilities rest on a robust database exceeding 100 billion real data points. This invaluable resource serves to continuously hone validated algorithms through a proprietary industry-quality control system.
Ozelle extends an invitation to all attendees at WHX Labs Dubai (Stand S1.D58) for live demonstrations and interactive sessions. Witness firsthand how AI × CBM is set to shape the future of diagnostic testing. For personalized demonstrations or to arrange a meeting, contacting Ozelle is highly encouraged. With innovative advancements in diagnostics, Ozelle emphasizes the importance of transforming healthcare for better outcomes, aligning with the future of medicine.
For more information, visit www.ozellemed.com or reach out via email to [email protected]
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.